Numerous investigations utilizing large-scale metagenomic cohort studies on CRC have identified 7 bacterial species that are notably enriched in CRC patients across 526 metagenomic samples from multiple countries, including Bacteroides fragilis and Fusobacterium nucleatum (Fn). This evidence concerns the gene FN1 and colorectal carcinoma.